ArticleF&S reports2026
Spontaneous ovarian hyperstimulation syndrome with a previously undescribed gene mutation of the follicle-stimulating hormone receptor gene: a case report.
Article in F&S reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To present a case of a patient with recurrent spontaneous ovarian hyperstimulation syndrome (sOHSS) and a previously undescribed mutation of the follicle-stimulating hormone receptor (FSHR). Design: Case report. Subjects: A 23-year-old pregnant woman (gravida II) with recurrent spontaneous ovarian hyperstimulation during 2 consecutive singleton pregnancies. Exposure: Spontaneous conception in the presence of a heterozygous FSHR gene mutation. Main Outcome Measures: Clinical course of sOHSS, hormonal profile, sonographic findings, molecular genetic results, and maternal and fetal outcomes. Results: The patient presented at 12 weeks' gestation with massively enlarged bilateral multicystic ovaries (‟kissing ovaries") and mild ascites, without pleural effusion. Molecular genetic analysis revealed a previously unreported heterozygous FSHR mutation (c.1379T>A, p.Leu460Gln) in the transmembrane domain, classified as likely pathogenic according to American College of Medical Genetics and Genomics criteria. Conservative management resulted in gradual regression of ovarian size from the second trimester onward. The pregnancy was complicated by fetal growth restriction with normal uteroplacental and fetal perfusion parameters. Delivery by elective cesarean section at 38+0 weeks resulted in a healthy neonate. Conclusion: The discovery of a novel FSHR gene mutation, which is likely associated with sOHSS in this case, suggests that genetic factors may influence the development of this rare condition. It underlines the importance of considering genetic testing in managing and diagnosing sOHSS, potentially guiding more personalized and effective treatment strategies for affected women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.